Scalability / ARR ceiling
4/10
The panel's call on
Telehealth startup focused at identifying microplastics in your blood
A lot of people are worried about microplastics these days. Have a team of qualified specialists as well to asses and meet with the "patient" and prescribe what is needed. Platform gets cut
Scored 7/29/2026, 10:34:13 AM
38/100
Likely a passBeats 0% of ideas scored
The bottom line
LockedPursue it, pilot it, or walk away — the panel has made its call. It's in the full analysis below.
Just the number, none of the idea — safe to drop anywhere.
Where it's strong, where it breaks — every angle, 0–10
The full breakdown — what each score is hiding
Effort-to-reward ratio
2/10
The scores are free. The reasoning isn't.
Unlock the full analysis — $5
You can see where your idea scored. What you can't see yet is the 35 findings behind those numbers — which is the part that tells you what to change.
- All 10 write-ups — the reasoning behind every score, in the panel's own words
- The bottom-line call: pursue it, pilot it, or walk away
- A permanent link emailed to you, so the report is yours to keep
One-off payment. No account, no subscription. Card handled by Stripe.
Time input required
3/10
Capital requirements
2/10
Transferability / sellability
4/10
Marketing & audience reachability
6/10
Differentiation potential
3/10
Competitive landscape / barriers
4/10
Regulatory / legal risk
2/10
Timing / market trend
8/10
Now put your idea in front of the panel.
Ten PhD-level business analysts, ten angles, one honest score out of 100. One sentence is enough to start.
Score my idea